Maternal care for other rhesus isoimmunization, second trimester (fetus 4)
ICD-10 O36.0924 is a billable code used to indicate a diagnosis of maternal care for other rhesus isoimmunization, second trimester (fetus 4).
Maternal care for rhesus isoimmunization involves monitoring and managing the health of the mother and fetus when the mother has developed antibodies against the Rh factor, which can lead to hemolytic disease in the fetus. In the second trimester, particularly for the fourth fetus, careful assessment is crucial as the risk of complications such as fetal growth restriction and fetal distress increases. The condition requires close surveillance through ultrasound examinations to monitor fetal growth and well-being, as well as potential interventions such as intrauterine transfusions if severe anemia is detected. Maternal care may also include Rh immunoglobulin administration to prevent further sensitization and complications in future pregnancies. The management plan should be tailored to the individual needs of the mother and fetus, considering the unique challenges posed by multiple pregnancies and the potential for increased morbidity.
Detailed records of maternal health, fetal monitoring results, and interventions performed are essential.
Management of isoimmunization in pregnant women with a history of Rh incompatibility, monitoring for fetal distress.
Consideration of maternal history and previous pregnancies is crucial for accurate coding.
Comprehensive documentation of high-risk factors, ultrasound findings, and any procedures performed.
Assessment and management of fetal anemia due to isoimmunization, planning for potential transfusions.
High-risk pregnancies require a multidisciplinary approach and thorough documentation of all care provided.
Used for monitoring fetal growth and well-being in cases of isoimmunization.
Document the reason for the ultrasound and findings related to fetal health.
Obstetricians should ensure that all ultrasound findings are clearly linked to the diagnosis.
Accurate coding of O36.0924 is crucial for ensuring appropriate maternal care and monitoring for complications associated with rhesus isoimmunization, which can significantly impact fetal health.
